Childress, Ann C.
Center for Psychiatry and Behavioral Medicine
26 papers on CoChatORCID 0000-0001-5782-7891
Most cited papers
- Verified
Practitioner Review: Emotional Dysregulation in Attention-deficit/Hyperactivity Disorder—Implications for Clinical Recognition and Intervention
Faraone, S. V., Rostain, A. L., Blader, J., Busch, B., Childress, A. C., Connor, D. F., & Newcorn, J. H. (2019) · Journal of Child Psychology and Psychiatry
Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development
Cited by 400
- Verified
Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts Extended-Release in Children with ADHD: A Double-Blind, Placebo-Controlled, Crossover Analog Classroom Study
Biederman, J., Boellner, S. W., Childress, A., Lopez, F. A., Krishnan, S., & Zhang, Y. (2007) · Biological Psychiatry
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 356
- Verified
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
Findling, R. L., Childress, A. C., Cutler, A. J., Gasior, M., Hamdani, M., Ferreira-Cornwell, M. C., & Squires, L. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment
Cited by 120
- Verified
A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
the 311 Study Group, Wigal, S. B., Kollins, S. H., Childress, A. C., & Squires, L. (2009) · Child and Adolescent Psychiatry and Mental Health
Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment
Cited by 110
- Verified
Long-Term Effectiveness and Safety of Lisdexamfetamine Dimesylate in School-Aged Children with Attention-Deficit/Hyperactivity Disorder
Findling, R. L., Childress, A. C., Krishnan, S., & McGough, J. J. (2008) · CNS Spectrums
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 90
- Verified
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents
Childress, A. C., & Berry, S. A. (2012) · Drugs
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 77
- Verified
The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder
Herscu, P., Handen, B. L., Arnold, L. E., Snape, M. F., Bregman, J. D., Ginsberg, L., Hendren, R., Kolevzon, A., Melmed, R., Mintz, M., et al. (2020) · Journal of Autism and Developmental Disorders
Autism Spectrum Disorder ResearchObsessive-Compulsive Spectrum Disorders
Cited by 62
- Verified
Varying the Wear Time of the Methylphenidate Transdermal System in Children With Attention-Deficit/Hyperactivity Disorder
WILENS, T. E., BOELLNER, S. W., LÓPEZ, F. A., TURNBOW, J. M., WIGAL, S. B., CHILDRESS, A. C., ABIKOFF, H. B., & MANOS, M. J. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 58
- Verified
Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective
Schein, J., Adler, L. A., Childress, A., Gagnon-Sanschagrin, P., Davidson, M., Kinkead, F., Cloutier, M., Guérin, A., & Lefebvre, P. (2022) · Journal of Managed Care & Specialty Pharmacy
Attention Deficit Hyperactivity DisorderHealth Systems, Economic Evaluations, Quality of Life
Cited by 56
- Verified
Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder
Newcorn, J. H., Nagy, P., Childress, A. C., Frick, G., Yan, B., & Pliszka, S. (2017) · CNS Drugs
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 50
- Verified
Efficacy and Duration of Effect of Extended-Release Dexmethylphenidate Versus Placebo in Schoolchildren With Attention-Deficit/Hyperactivity Disorder
Silva, R. R., Muniz, R., Pestreich, L., Childress, A., Brams, M., Lopez, F. A., & Wang, J. (2006) · Journal of Child and Adolescent Psychopharmacology
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 44
- Verified
A Long-Term Open-Label Safety and Effectiveness Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
Findling, R. L., Cutler, A. J., Saylor, K., Gasior, M., Hamdani, M., Ferreira-Cornwell, M. C., & Childress, A. C. (2013) · Journal of Child and Adolescent Psychopharmacology
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 40
- Verified
Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules Administered Once Daily to Children with Attention-Deficit/Hyperactivity Disorder
Childress, A. C., Spencer, T., Lopez, F., Gerstner, O., Thulasiraman, A., Muniz, R., & Post, A. (2009) · Journal of Child and Adolescent Psychopharmacology
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 34
- Verified
The Effects of Lisdexamfetamine Dimesylate on Emotional Lability in Children 6 to 12 Years of Age With ADHD in a Double-Blind Placebo-Controlled Trial
Childress, A. C., Arnold, V., Adeyi, B., Dirks, B., Babcock, T., Scheckner, B., Lasser, R., & Lopez, F. A. (2014) · Journal of Attention Disorders
Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment
Cited by 33
- Verified
Relationship between symptomatic and functional improvement and remission in a treatment response to stimulant trial
Weiss, M., Childress, A., Mattingly, G., Nordbrock, E., Kupper, R. J., & Adjei, A. L. (2018) · Journal of Child and Adolescent Psychopharmacology
Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology
Cited by 30
- Verified
Open-Label Administration of Lisdexamfetamine Dimesylate Improves Executive Function Impairments and Symptoms of Attention-Deficit/Hyperactivity Disorder in Adults
Brown, T. E., Brams, M., Gao, J., Gasior, M., & Childress, A. (2010) · Postgraduate Medicine
Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior
Cited by 29
- Verified
Changes in Emotions Related to Medication Used to Treat ADHD. Part I: Literature Review
Manos, M. J., Brams, M., Childress, A. C., Findling, R. L., López, F. A., & Jensen, P. S. (2011) · Journal of Attention Disorders
Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development
Cited by 28
- Verified
Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy
Childress, A. C., & Sallee, F. R. (2015) · CNS Drugs
Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development
Cited by 23
- Verified
Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day
Wigal, S. B., Kollins, S. H., Childress, A. C., & Adeyi, B. (2010) · Child and Adolescent Psychiatry and Mental Health
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 23
- Verified
The use of lisdexamfetamine dimesylate for the treatment of ADHD
Childress, A. C., & Sallee, F. R. (2012) · Expert Review of Neurotherapeutics
Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior
Cited by 18
- Verified
SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study
Brams, M., Childress, A. C., Greenbaum, M., Yu, M., Yan, B., Jaffee, M., & Robertson, B. (2018) · Journal of Child and Adolescent Psychopharmacology
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 12
- Verified
ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years
López, F. A., Childress, A., Adeyi, B., Dirks, B., Babcock, T., Scheckner, B., Lasser, R. A., Shepski, J., & Arnold, V. (2017) · Journal of Attention Disorders
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 11
- Verified
Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/ hyperactivity disorder
Schein, J., Cloutier, M., Gauthier-Loiselle, M., Bungay, R., Chen, K., Chan, D., & Childress, A. (2024) · Journal of Managed Care & Specialty Pharmacy
Attention Deficit Hyperactivity DisorderHealth Systems, Economic Evaluations, Quality of Life
Cited by 6
- Verified
Gender Effects in the Efficacy of Racemic Amphetamine Sulfate in Children with Attention-Deficit/Hyperactivity Disorder
Childress, A. C., Newcorn, J. H., & Cutler, A. J. (2019) · Advances in Therapy
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free